Actionable news
0
All posts from Actionable news
Actionable news in VRX: VALEANT PHARMACEUTICALS INTERNATIONAL,

Valeant Gets FDA OK for Anticonstipation Tablets Developed by Progenics

The Food and Drug Administration granted Valeant Pharmaceuticals Inc. approval for Relistor tablets to treat...

Progenics shares rose 36% to $6.74 in after-hours trading. Valeant was up 4% to $24.50.

Valeant expects to begin U.S. sales of Relistor tablets in the third quarter.

Progenics previously said FDA approval would trigger a $50 million milestone payment. Relistor was the first commercial...


More